Literature DB >> 922357

Post-marketing surveillance of adverse reactions to new medicines.

A B Wilson.   

Abstract

Mesh:

Year:  1977        PMID: 922357      PMCID: PMC1631773          DOI: 10.1136/bmj.2.6093.1001

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  Use of medicines in general practice.

Authors:  D C Skegg; R Doll; J Perry
Journal:  Br Med J       Date:  1977-06-18

2.  Drug monitoring and adverse reactions.

Authors:  J G Howie
Journal:  Br Med J       Date:  1977-06-04

3.  Monitoring adverse reactions to new drugs: "restricted release" or "monitored release"?

Authors:  D H Lawson; D A Henry
Journal:  Br Med J       Date:  1977-03-12

4.  The discovery of drug-induced illness.

Authors:  H Jick
Journal:  N Engl J Med       Date:  1977-03-03       Impact factor: 91.245

5.  Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol).

Authors:  P Brown; H Baddeley; A E Read; J D Davies; J McGarry
Journal:  Lancet       Date:  1974-12-21       Impact factor: 79.321

  5 in total
  14 in total

1.  After practolol.

Authors: 
Journal:  Br Med J       Date:  1977-12-17

2.  Post-marketing surveillance in the UK (1984).

Authors:  D H Lawson
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

3.  Identification of adverse reactions to new drugs. I: What have been the important adverse reactions since thalidomide?

Authors:  G R Venning
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-15

4.  Post-marketing drug surveillance.

Authors:  R J Walden; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-09       Impact factor: 4.335

5.  Postmarketing surveillance of adverse reactions to drugs.

Authors:  M D Rawlins
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-24

6.  Acute intoxication and illness due to mild analgesics.

Authors:  E P Fournier
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

7.  [Drug safety: activities of the manufacturer].

Authors:  P Krupp
Journal:  Soz Praventivmed       Date:  1980-03

8.  Post marketing drug surveillance, another string to the bow.

Authors:  P J Fell; N P Watson; H F O'Donnell
Journal:  Eur J Clin Pharmacol       Date:  1978-06-19       Impact factor: 2.953

9.  Post marketing surveillance of captopril (for hypertension): a preliminary report.

Authors:  D Chalmers; S L Dombey; D H Lawson
Journal:  Br J Clin Pharmacol       Date:  1987-09       Impact factor: 4.335

10.  Postmarketing surveillance: practical experience with ketotifen.

Authors:  W P Maclay; D Crowder; S Spiro; P Turner
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.